Leishmania is not prone to develop resistance to tamoxifen

Tamoxifen, an antineoplastic agent, is active in vitro and in vivo against the parasitic protozoa Leishmania. As part of our efforts to unravel this drug's mechanisms of action against the parasite and understand how resistance could arise, we tried to select tamoxifen-resistant Leishmania amaz...

Full description

Bibliographic Details
Main Authors: Adriano C. Coelho, Cristiana T. Trinconi, Luisa Senra, Jenicer K.U. Yokoyama-Yasunaka, Silvia R.B. Uliana
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320715300026